Question 1

- question: "How does ketamine help treat depression?

Accepted Answer

Ketamine works through a fundamentally different mechanism than traditional antidepressants. Rather than targeting serotonin or norepinephrine, ketamine blocks NMDA glutamate receptors, which triggers a cascade of downstream effects including increased release of brain-derived neurotrophic factor (BDNF) and activation of the mTOR signaling pathway. These molecular changes promote rapid synaptogenesis, the formation of new synaptic connections in brain regions affected by depression such as the prefrontal cortex and hippocampus. Research published in Science by Bhatt and Bhatt and colleagues has shown that ketamine can restore synaptic connections that are damaged by chronic stress and depression, essentially helping to rewire neural circuits involved in mood regulation. For more on the science, see [neuroplasticity and ketamine](/research/neuroplasticity-and-ketamine/).

Question 2

How quickly does ketamine work for depression?

Accepted Answer

One of ketamine's most remarkable properties is its rapid onset of antidepressant action. Many patients report noticeable improvement within hours of their first infusion, with significant effects often apparent within 24 hours. This stands in stark contrast to traditional antidepressants like SSRIs, which typically require four to six weeks to reach full efficacy. A landmark study by Berman and colleagues published in Biological Psychiatry in 2000 first demonstrated this rapid antidepressant effect. Subsequent research has confirmed that approximately [50 to 70 percent of patients](/research/ketamine-response-rate/) with treatment-resistant depression experience meaningful symptom reduction within 24 hours of a single intravenous ketamine infusion at 0.5 mg/kg.

Question 3

How long do the antidepressant effects of ketamine last?

Accepted Answer

The duration of antidepressant response varies significantly between individuals. After a single intravenous infusion, the antidepressant effect typically lasts one to two weeks, with some patients experiencing relief for up to a month and others relapsing within days. A series of six infusions over two to three weeks generally produces a more sustained response than a single treatment. Research from the National Institute of Mental Health has shown that repeated infusions can extend the duration of benefit. [Maintenance infusions](/protocols/maintenance-infusion-protocols/) are usually needed to sustain improvement, with the interval between treatments tailored to each patient's response. Some patients eventually achieve stable remission with decreasing treatment frequency over time.

Question 4

Who responds best to ketamine for depression?

Accepted Answer

Research has identified several factors associated with a better response to ketamine therapy. Patients with treatment-resistant depression who have failed multiple conventional antidepressants often respond well, with studies showing response rates of 50 to 70 percent. Those with prominent anhedonia, or the inability to feel pleasure, may be particularly likely to benefit. A higher body mass index and family history of alcohol use disorder have been associated with better response in some studies. Patients with significant anxiety comorbidity also tend to respond favorably. Conversely, those with active substance use disorders, personality disorders, or psychotic features may have lower response rates. Your provider can help assess the likelihood of benefit based on your clinical profile.

Question 5

Can ketamine help with suicidal thoughts?

Accepted Answer

Yes, ketamine has demonstrated a rapid and significant anti-suicidal effect that is one of its most clinically important properties. Multiple studies, including a meta-analysis published in the American Journal of Psychiatry, have shown that a single ketamine infusion can reduce suicidal ideation within hours. This effect appears to be at least partially independent of its antidepressant action, suggesting a distinct anti-suicidal mechanism. Emergency departments and inpatient psychiatric units have begun incorporating ketamine into crisis protocols. FDA-approved esketamine (Spravato) received a specific indication for major depressive disorder with acute suicidal ideation or behavior in 2020. If you are experiencing suicidal thoughts, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.

Question 6

What if ketamine does not work for my depression?

Accepted Answer

Approximately 30 to 50 percent of patients with treatment-resistant depression do not respond to ketamine therapy. If you complete an initial series of six infusions without meaningful improvement, your provider may consider several options. These include adjusting the dose, trying a different route of administration such as switching from intranasal to intravenous, or combining ketamine with psychotherapy to enhance the therapeutic effect. Some non-responders to racemic ketamine may respond to esketamine or vice versa. Other evidence-based alternatives for treatment-resistant depression include transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), vagus nerve stimulation, and newer agents such as psilocybin-assisted therapy in clinical trial settings.

Question 7

Is ketamine effective for bipolar depression?

Accepted Answer

Emerging evidence suggests that ketamine can be effective for the depressive phase of bipolar disorder, though research is less extensive than for unipolar depression. Studies published in Bipolar Disorders and the Journal of Clinical Psychiatry have shown rapid antidepressant effects similar to those observed in unipolar depression, with response rates ranging from 40 to 60 percent. A key clinical concern is the theoretical risk of triggering a manic or hypomanic episode. However, clinical studies have reported very low rates of treatment-emergent mania with low-dose ketamine. Most providers require patients with bipolar disorder to be on a mood stabilizer before initiating ketamine therapy as a precautionary measure.

Question 8

How does ketamine compare to traditional antidepressants?

Accepted Answer

Ketamine differs from traditional antidepressants in several important ways. The most notable difference is speed of onset. While SSRIs, SNRIs, and tricyclic antidepressants require weeks to months to take effect, ketamine can produce antidepressant effects within hours. Ketamine targets the glutamate system rather than the monoamine systems targeted by most conventional medications. Its efficacy in treatment-resistant patients who have failed multiple standard medications is particularly significant. However, ketamine requires ongoing administration to maintain effects, must be given under medical supervision, and has a different side effect profile including dissociation and potential for misuse. Traditional antidepressants remain the first-line treatment, with ketamine reserved for cases where conventional approaches have proven insufficient.

Ketamine for Depression

Frequently Asked Questions

Related Reading

Low-Dose Ketamine and Cannabis: What Patients Should Know

Drug Interactions and Contraindications

Dosing and Administration